Research suggests that a complete absence of IL‐18 (or its receptor IL‐18R) makes mice more susceptible to intestinal epithelial harm, and creates a modified inflammatory milieu that enhances the potential for intestinal tumor development [48, 49]. Here, IL18R1 is linked to neoplasm.